SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-16
👔
CLOVER HEALTH INVESTMENTS, CORP. /DE
@CLOV_InsiderForm 4 Filing: Wai Conrad Sells $113,084.05 of $CLOV
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
CLOVER HEALTH INVESTMENTS, CORP. /DE
Ticker: $CLOV
Transaction Value
$113,084.05
Price/Share: $4.67
transaction date
2026-07-15
Shares: 24,215
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Wai Conrad, holds the title of CEO, Counterpart Health at CLOVER HEALTH INVESTMENTS, CORP. /DE.
On 2026-07-15, the insider transacted 24,215 shares.The shares were transacted at a weighted average price of $4.67 per share, resulting in a total market-relevant value of $113,084.05.
Executive Summary Summary
Wai Conrad (CEO, Counterpart Health) sold $113K of $CLOV
Post-Transaction Position: 1,145,699 shares
SEC Accession No: 0001801170-26-000178 (CIK: 1971702)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.